<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03258697</url>
  </required_header>
  <id_info>
    <org_study_id>201602050A3</org_study_id>
    <nct_id>NCT03258697</nct_id>
  </id_info>
  <brief_title>The Pharmacokinetics and Effectiveness of Local LevoBupivacaine Injection on Primary Total Joint Replacement Model.</brief_title>
  <official_title>The Pharmacokinetics and Effectiveness of Different Methods of Local LevoBupivacaine Injection, a Prospective Randomized Case Control Clinical Study on Primary Total Joint Replacement Model.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Chang Gung Memorial Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Chang Gung Memorial Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Total joint replacement is an ideal procedure to treat end stage joint disease. Good post-op
      pain relief could accelerate patient recovery and rehabilitation, and decrease admission days
      and medical cost. Local injection of LevoBupivacaine is an effective method in post-operative
      pain control. The effectiveness of local analgesia was noticed clinically. However, thorough
      studies about the pharmacokinetics of LevoBupivacaine, maintenance of effect, influence of
      post-operative rehabilitation are not well studied in different way of injection. The purpose
      of this study is to evaluate and analyze the pharmacokinetics and effect of local
      Levobupivacaine injection in different ways, the amount of post-operative fentanyl
      requirement after local injection, time to first fentanyl request, pain score, immediate
      post-operative function, side effect of analgesic agents, and medical cost, and to improve
      the quality of total joint replacement post-operative care.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Single large dose of LevoBupivacaine had been proved good analgesic effect in total joint
      replacement surgery. However, the safety was not well studied. For better understanding the
      effect and safety of local analgesic agent, we choose LevoBupivacaine with different
      injection way to find out. We divide patient to three groups, for comparing the effectiveness
      of LevoBupivacaine, and safety of LevoBupivacaine by checking intra-blood concentration. The
      pre-emptive analgesics and post-operative analgesics were the same as routine protocol in
      other total joint replacement.
    </textblock>
  </detailed_description>
  <overall_status>Enrolling by invitation</overall_status>
  <start_date type="Actual">October 17, 2017</start_date>
  <completion_date type="Anticipated">February 28, 2020</completion_date>
  <primary_completion_date type="Anticipated">August 31, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Dosage of analgesic opioid agent</measure>
    <time_frame>post-operative day2</time_frame>
    <description>The total dosage of opioid agent after local LevoBupivacaine injection</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Blood concentration of LevoBupivacaine</measure>
    <time_frame>25min, 90min, and coming morning after LevoBupivacaine injection</time_frame>
    <description>Venous return of local LevoBupivacaine could cause the difference of blood concentration</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Functional score</measure>
    <time_frame>Baseline, Post-operative day1, day2, week2, week6, week12, week24</time_frame>
    <description>The difference of functional score</description>
  </other_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">180</enrollment>
  <condition>Arthropathy</condition>
  <arm_group>
    <arm_group_label>Patient-Controlled Analgesia</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Patient had no local analgesic agent during total joint replacement. Patient had baseline Patient-Controlled Analgesia pump.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Peri-articular LevoBupivacaine</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patient had periarticular local analgesic agent, LevoBupivacaine Hydrochloride, during total joint replacement. Patient had baseline Patient-Controlled Analgesia pump.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Intra-articular LevoBupivacaine</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patient had intra-articular local analgesic agent, LevoBupivacaine Hydrochloride, during total joint replacement. Patient had baseline Patient-Controlled Analgesia pump.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Levobupivacaine Hydrochloride</intervention_name>
    <description>Different way of LevoBupivacaine injection</description>
    <arm_group_label>Peri-articular LevoBupivacaine</arm_group_label>
    <arm_group_label>Intra-articular LevoBupivacaine</arm_group_label>
    <other_name>Chirocaine</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Primary total joint replacement, no previous open surgery on the same joint

          2. Age 50~80 y/o, Pre-operative diagnosis: degenerative osteoarthritis

          3. Pre-operative deformity: varus &lt;15°, valgus &lt;15°, flexion contracture &lt;15°.

          4. Patients with normal heart function

          5. Willing to receive post-operative questionnaire and outpatient clinic follow-up

        Exclusion Criteria:

          1. Allergy to Patient-Controlled Analgesia or LevoBupivacaine

          2. Mental or cognitive illness that couldn't well response to questionnaire

          3. American Society Anesthesiologist more than III degree

          4. Liver cirrhosis, chronic renal insufficiency, heart disease or arrhythmia,
             insulin-dependent diabetes mellitus, and previous narcotic abuse history.

          5. Not suitable for using patient-controlled analgesia pump by evaluation of
             anesthesiologist
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>50 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Wei-Chen Lo, M.S.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Chang Gung Memorial Hospital, Linkou, Taiwan</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Chang Gung Memorial Hospital, Linkou</name>
      <address>
        <city>Taoyuan City</city>
        <zip>333</zip>
        <country>Taiwan</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Taiwan</country>
  </location_countries>
  <reference>
    <citation>Chen CC, Yang CC, Hu CC, Shih HN, Chang YH, Hsieh PH. Acupuncture for pain relief after total knee arthroplasty: a randomized controlled trial. Reg Anesth Pain Med. 2015 Jan-Feb;40(1):31-6. doi: 10.1097/AAP.0000000000000138.</citation>
    <PMID>25158837</PMID>
  </reference>
  <reference>
    <citation>Chen DW, Hu CC, Chang YH, Lee MS, Chang CJ, Hsieh PH. Intra-articular bupivacaine reduces postoperative pain and meperidine use after total hip arthroplasty: a randomized, double-blind study. J Arthroplasty. 2014 Dec;29(12):2457-61. doi: 10.1016/j.arth.2013.12.021. Epub 2013 Dec 19.</citation>
    <PMID>24439998</PMID>
  </reference>
  <reference>
    <citation>Parvataneni HK, Shah VP, Howard H, Cole N, Ranawat AS, Ranawat CS. Controlling pain after total hip and knee arthroplasty using a multimodal protocol with local periarticular injections: a prospective randomized study. J Arthroplasty. 2007 Sep;22(6 Suppl 2):33-8. Epub 2007 Jul 26.</citation>
    <PMID>17823012</PMID>
  </reference>
  <reference>
    <citation>Wasudev G, Smith BE, Limbird TJ. Blood levels of bupivacaine after arthroscopy of the knee joint. Arthroscopy. 1990;6(1):40-2.</citation>
    <PMID>2310449</PMID>
  </reference>
  <reference>
    <citation>Meinig RP, Holtgrewe JL, Wiedel JD, Christie DB, Kestin KJ. Plasma bupivacaine levels following single dose intraarticular instillation for arthroscopy. Am J Sports Med. 1988 May-Jun;16(3):295-300.</citation>
    <PMID>3381989</PMID>
  </reference>
  <verification_date>August 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 16, 2017</study_first_submitted>
  <study_first_submitted_qc>August 22, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">August 23, 2017</study_first_posted>
  <last_update_submitted>January 29, 2018</last_update_submitted>
  <last_update_submitted_qc>January 29, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">January 30, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Local analgesia, Pharmacokinetics, Total joint replacement</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Joint Diseases</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Levobupivacaine</mesh_term>
    <mesh_term>Bupivacaine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

